Debates & Insight Sponsored Next-generation brand launches: Global health data and insig... Life Sciences companies face challenges today in achieving their revenue forecast and return on investment from brand launches.
Debates & Insight Sponsored Computer Gaming: The Future of Decision-Making for Life Scie... How can life science brands identify winning strategic decisions when there are so many variables to consider?
Debates & Insight Sponsored Pricing & Market Access Outlook 2014 Pricing and market access are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need, becomes i
Debates & Insight Sponsored Available on-demand: Real world insight into diabetes manage... Now available on demand (free to access) - originally broadcast on October 29th 2014.
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.